Hao Shi

4.3k total citations · 4 hit papers
73 papers, 2.4k citations indexed

About

Hao Shi is a scholar working on Molecular Biology, Immunology and Physiology. According to data from OpenAlex, Hao Shi has authored 73 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 20 papers in Immunology and 13 papers in Physiology. Recurrent topics in Hao Shi's work include Muscle Physiology and Disorders (15 papers), Immune Cell Function and Interaction (14 papers) and T-cell and B-cell Immunology (10 papers). Hao Shi is often cited by papers focused on Muscle Physiology and Disorders (15 papers), Immune Cell Function and Interaction (14 papers) and T-cell and B-cell Immunology (10 papers). Hao Shi collaborates with scholars based in United States, China and United Kingdom. Hao Shi's co-authors include Hongbo Chi, Yogesh Dhungana, Nicole M. Chapman, David E. Gerrard, Jordy Saravia, Seon Ah Lim, Peter Vogel, Gustavo Palacios, Lingyun Long and Jun Wei and has published in prestigious journals such as Nature, Cell and Journal of Biological Chemistry.

In The Last Decade

Hao Shi

71 papers receiving 2.4k citations

Hit Papers

Lipid signalling enforces functional specialization of Tr... 2021 2026 2022 2024 2021 2023 2023 2025 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hao Shi United States 27 1.1k 801 382 354 328 73 2.4k
Dorina Avram United States 31 1.3k 1.2× 1.3k 1.6× 344 0.9× 184 0.5× 243 0.7× 60 2.9k
Akula Bala Pramod United States 16 1.2k 1.1× 1.3k 1.6× 301 0.8× 207 0.6× 141 0.4× 29 2.7k
Bin Ma China 26 1.0k 1.0× 484 0.6× 279 0.7× 374 1.1× 141 0.4× 84 2.3k
Pelagia Foka Greece 17 949 0.9× 340 0.4× 249 0.7× 252 0.7× 186 0.6× 35 1.9k
Yan Zhou China 28 1.3k 1.2× 331 0.4× 191 0.5× 425 1.2× 145 0.4× 130 2.3k
Kotaro Sugimoto Japan 23 962 0.9× 331 0.4× 239 0.6× 321 0.9× 177 0.5× 54 2.1k
Yasuyuki Kitaura Japan 24 1.2k 1.1× 286 0.4× 258 0.7× 323 0.9× 402 1.2× 62 2.0k
Kazumi Ishidoh Japan 34 1.7k 1.6× 510 0.6× 323 0.8× 616 1.7× 526 1.6× 74 3.1k
Douglas J. Mahoney Canada 27 2.2k 2.0× 838 1.0× 637 1.7× 645 1.8× 609 1.9× 64 3.9k

Countries citing papers authored by Hao Shi

Since Specialization
Citations

This map shows the geographic impact of Hao Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Shi more than expected).

Fields of papers citing papers by Hao Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Shi. The network helps show where Hao Shi may publish in the future.

Co-authorship network of co-authors of Hao Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Hao Shi. A scholar is included among the top collaborators of Hao Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao Shi. Hao Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuan, Sujing, Renqiang Sun, Hao Shi, et al.. (2025). VDAC2 loss elicits tumour destruction and inflammation for cancer therapy. Nature. 640(8060). 1062–1071. 17 indexed citations breakdown →
2.
Mavuluri, Jayadev, Yogesh Dhungana, Lindsay L. Jones, et al.. (2025). GPR65 Inactivation in Tumor Cells Drives Antigen-Independent CAR T-cell Resistance via Macrophage Remodeling. Cancer Discovery. 15(5). 1018–1036. 2 indexed citations
3.
Shi, Hao, Sidi Chen, & Hongbo Chi. (2024). Immunometabolism of CD8+ T cell differentiation in cancer. Trends in cancer. 10(7). 610–626. 22 indexed citations
4.
Liu, Nannan, Dan Wang, Xin Wang, et al.. (2023). PM2.5-bound metals and blood metals are associated with pulmonary function and Th17/Treg imbalance: A panel study of asthmatic adults. Chemosphere. 340. 139869–139869. 7 indexed citations
5.
Guo, Chuansheng, Zhiyuan You, Hao Shi, et al.. (2023). SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity. Nature. 620(7972). 200–208. 154 indexed citations breakdown →
7.
Shi, Hao, et al.. (2023). PM2.5 induces the inflammatory response in rat spleen lymphocytes through autophagy activation of NLRP3 inflammasome. Molecular Immunology. 161. 74–81. 3 indexed citations
8.
Shi, Hao, John G. Doench, & Hongbo Chi. (2022). CRISPR screens for functional interrogation of immunity. Nature reviews. Immunology. 23(6). 363–380. 48 indexed citations
9.
Lim, Seon Ah, Jun Wei, Thanh-Long M. Nguyen, et al.. (2021). Lipid signalling enforces functional specialization of Treg cells in tumours. Nature. 591(7849). 306–311. 286 indexed citations breakdown →
10.
Shi, Hao, et al.. (2021). Skeletal Muscle O-GlcNAc Transferase Action on Global Metabolism Is Partially Mediated Through Interleukin-15. Frontiers in Physiology. 12. 682052–682052. 4 indexed citations
11.
Huang, Hongling, Peipei Zhou, Jun Wei, et al.. (2021). In vivo CRISPR screening reveals nutrient signaling processes underpinning CD8+ T cell fate decisions. Cell. 184(5). 1245–1261.e21. 95 indexed citations
12.
Wang, Caihong, Dan Wang, Jing Wang, et al.. (2021). Traffic-related PM2.5 and diverse constituents disturb the balance of Th17/Treg cells by STAT3/RORγt-STAT5/Foxp3 signaling pathway in a rat model of asthma. International Immunopharmacology. 96. 107788–107788. 23 indexed citations
13.
Su, Wei, Nicole M. Chapman, Jun Wei, et al.. (2020). Protein Prenylation Drives Discrete Signaling Programs for the Differentiation and Maintenance of Effector Treg Cells. Cell Metabolism. 32(6). 996–1011.e7. 39 indexed citations
14.
Zhou, Yuan, Yu Chen, Jun Guo, et al.. (2019). Icariin attenuate microcystin-LR-induced gap junction injury in Sertoli cells through suppression of Akt pathways. Environmental Pollution. 251. 328–337. 25 indexed citations
15.
Shi, Hao, Haiyan Tan, Yuxin Li, et al.. (2018). Hippo Kinases Mst1 and Mst2 Sense and Amplify IL-2R-STAT5 Signaling in Regulatory T Cells to Establish Stable Regulatory Activity. Immunity. 49(5). 899–914.e6. 87 indexed citations
16.
Zeng, Hu, Mei Yu, Haiyan Tan, et al.. (2018). Discrete roles and bifurcation of PTEN signaling and mTORC1-mediated anabolic metabolism underlie IL-7–driven B lymphopoiesis. Science Advances. 4(1). eaar5701–eaar5701. 35 indexed citations
17.
Siegel, P.B., et al.. (2018). Long-term selection of chickens for body weight alters muscle satellite cell behaviors. Poultry Science. 97(7). 2557–2567. 15 indexed citations
18.
Zhou, Yuan, Xiao Geng, Yu Chen, et al.. (2018). Essential roles of Akt/Snail pathway in microcystin-LR-induced tight junction toxicity in Sertoli cell. Food and Chemical Toxicology. 112. 290–298. 27 indexed citations
20.
Yang, Niuniu, Hao Shi, Guang Yu, et al.. (2016). Osthole inhibits histamine-dependent itch via modulating TRPV1 activity. Scientific Reports. 6(1). 25657–25657. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026